Suchergebnisse - "O'Connor, Owen A"

PubPharm (287)

21

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Ansell, S. | Maris, M. | Lesokhin, A. | +23

22

Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL)

enthalten in: Seminars in hematology | 2021

von Ma, H. | O'Connor, O. | Marchi, E.

23

Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma : updated results from an international multi-center phase I/II experience

enthalten in: Leukemia & lymphoma | 2020

von Sawas, A. | Ma, H. | Kuruvilla, J. | +10

24

N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB

enthalten in: iScience | 2020

von Kalac, M. | Mangone, M. | Rinderspacher, A. | +7

25

Cancer testis antigen expression across T-cell lymphoma subtypes

enthalten in: Hematological oncology | 2020

von Ma, H. | Soderquist, C. | Marchi, E. | +3

26

Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers

enthalten in: Genes, chromosomes & cancer | 2020

von Scotto, L. | Kinahan, C. | Casadei, B. | +9

27

A perspective on improving the R-CHOP regimen : from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise

enthalten in: The Lancet. Haematology | 2020

von Lue, J. | O'Connor, O.

28

The peripheral T-cell lymphomas : an unusual path to cure

enthalten in: The Lancet. Haematology | 2020

von Ma, H. | Marchi, E. | O'Connor, O.

29

Targeting pathogenic mechanisms in marginal zone lymphoma : from concepts and beyond

enthalten in: Annals of lymphoma | 2020

von Lue, J. | O'Connor, O. | Bertoni, F.

30

ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest

enthalten in: Oncotarget | 2020

von Scotto, L. | Serrano, X. | Zullo, K. | +5